trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast']
a new treatment is effective for advanced her2-low breast cancer treatment with trastuzumab deruxtecan increases progression-free survival and overall survival compared with the usual treatments info: #asco22 
Compte oficial de l'Hospital CLÍNIC de Barcelona. Tota l'actualitat en assistència i recerca.